| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -292K | 100% | $21.46 | -$6.26M |
| Net | -8 | -292K | -100% | -$6.26M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Eric M. Dube | CHIEF EXECUTIVE OFFICER, Director | $8.82M | -$1.91M | -17.8% | May 2, 2025 |
| Peter Heerma | Chief Commercial Officer | $2.32M | -$308K | -11.7% | Sep 23, 2025 |
| Elizabeth E. Reed | Chief Legal Officer and GC | $2.25M | -$766K | -25.4% | Sep 22, 2025 |
| William E. Rote | Chief Research Officer | $2.11M | -$414K | -16.4% | May 2, 2025 |
| Christopher R. Cline | Chief Financial Officer | $1.81M | -$178K | -8.92% | Sep 3, 2025 |
| Jeffrey Meckler | Director | $1.6M | May 15, 2025 | ||
| Sandra Calvin | Svp, Chief Accounting Officer | $1.36M | -$1.92M | -58.5% | Feb 11, 2025 |
| Steve Aselage | Director | $1.32M | May 11, 2022 | ||
| Jula Inrig | Chief Medical Officer | $1.3M | -$226K | -14.8% | Jul 1, 2025 |
| Lyons Gary A | Director | $1.05M | May 15, 2025 | ||
| Timothy Coughlin | Director | $1.02M | May 15, 2025 | ||
| Roy D. Baynes | Director | $687K | -$540K | -44% | May 15, 2025 |
| Ron Squarer | Director | $648K | May 15, 2025 | ||
| John A. Orwin | Director | $648K | May 15, 2025 | ||
| Sandra Poole | Director | $550K | May 15, 2025 | ||
| Suzanne Louise Bruhn | Director | $527K | May 15, 2025 | ||
| Laura Clague | Chief Financial Officer | $508K | May 10, 2022 | ||
| Brinkley Ruth Williams | Director | $472K | May 15, 2025 | ||
| Noah L. Rosenberg | Chief Medical Officer | $427K | Aug 13, 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|